|
FI20031420A
|
|
Process for the preparation of new 7-substituted-9- (substituted amino) -6-demethyl-6-deoxytetracyclines
|
|
CA2406504A1
|
|
Method of treating resistant tumors
|
|
WO02098369A2
|
|
Mutant forms of cholera holotoxin as an adjuvant
|
|
AU4442602A
|
|
Tricyclic benzazepine vasopressin antagonists
|
|
WO02086139A1
|
|
Antibiotic aa 896 analogs
|
|
WO02085867A1
|
|
Antibiotics aa-896
|
|
IL149127D0
|
|
Fungicidal methods, compounds and compositions containing benzophenones
|
|
US2002165229A1
|
|
Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases
|
|
US2002091149A1
|
|
Synergistic ectoparasiticidal methods and compositions
|
|
EP1343527A2
|
|
Adjuvant combination formulations
|
|
AU8933001A
|
|
3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
|
|
CA2357110A1
|
|
Method for the treatment of polycystic kidney disease
|
|
IL152930D0
|
|
Rescue of canine distemper virus from cdna
|
|
MXPA02012254A
|
|
Assembly of wild-type and chimeric influenza virus-like particles (vlps).
|
|
MXPA02012255A
|
|
Nucleotide sequence of influenza a/udorn/72 (h3n2) genome.
|
|
BR0111834A
|
|
Adjuvant and immunogenic compositions, and method for eliciting an immune response to an antigen
|
|
IL153004D0
|
|
Modified morbillivirus v proteins
|
|
CZ290340B6
|
|
Pyrimidine derivatives
|
|
US2002049320A1
|
|
6-amino-2,4-dioxo-3,4-dihydro-1,3,5-triazine derivatives and methods for the solid phase synthesis thereof
|
|
US6384051B1
|
|
Method of treating or inhibiting colonic polyps
|
